265 related articles for article (PubMed ID: 19437324)
21. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
Troeger A; Gudowius S; Escherich G; den Boer ML; Glouchkova L; Ackermann B; Meisel R; Laws HJ; Groeger M; Wessalowski R; Willers R; Harbott J; Pieters R; Goebel U; Janka-Schaub GE; Hanenberg H; Dilloo D
Br J Haematol; 2007 Nov; 139(3):450-7. PubMed ID: 17910636
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
23. [Transitional pre-B-cell ALL].
Yun C; Kamitamari A; Okada M; Nakatomi A; Moriuchi H
Rinsho Ketsueki; 2001 Feb; 42(2):94-8. PubMed ID: 11280923
[TBL] [Abstract][Full Text] [Related]
24. [Stages of B-lymphocyte differentiation in acute lymphoblastic leukemia].
Koehler M; Bubała H; Sońta-Jakimczyk D; Guzikowska E; Janik-Moszant A; Wieczorek M; Hołowiecki J
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):879-81, 884. PubMed ID: 2487942
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
26. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
27. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of a new marker for common acute lymphoblastic leukemia detected by two-dimensional electrophoresis.
Hanash SM; Kuick R; Nichols D; Stoolman L
Dis Markers; 1988; 6(4):209-20. PubMed ID: 2976630
[TBL] [Abstract][Full Text] [Related]
29. Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia.
Xi Y; Li J; Zan L; Wang J; Wang G; Ning Y
Hum Pathol; 2013 Jun; 44(6):1011-6. PubMed ID: 23260326
[TBL] [Abstract][Full Text] [Related]
30. Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemia.
Alvarez Y; Coll MD; Ortega JJ; Bastida P; Dastugue N; Robert A; Cervera J; Verdeguer A; Tasso M; Aventín A; Guitart M; Caballín MR
Cancer Genet Cytogenet; 2005 Oct; 162(1):21-9. PubMed ID: 16157196
[TBL] [Abstract][Full Text] [Related]
31. Significance of CD34/CD123 expression in detection of minimal residual disease in B-ACUTE lymphoblastic leukemia in children.
Zeidan MA; Kamal HM; El Shabrawy DA; Esh AM; Sattar RH
Blood Cells Mol Dis; 2016 Jul; 59():113-8. PubMed ID: 27282579
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia.
Pui CH; Rivera GK; Hancock ML; Raimondi SC; Sandlund JT; Mahmoud HH; Ribeiro RC; Furman WL; Hurwitz CA; Crist WM
Leukemia; 1993 Jan; 7(1):35-40. PubMed ID: 8418377
[TBL] [Abstract][Full Text] [Related]
33. [Prevalence and features of pre-B-cell acute lymphoblastic leukemia in Mexico: description of 9 patients].
Lobato-Mendizábal E; Ruiz-Argüelles GJ
Sangre (Barc); 1991 Feb; 36(1):1-5. PubMed ID: 1906639
[TBL] [Abstract][Full Text] [Related]
34. [Acute lymphatic leukemia with pre-B-cell characteristics].
Sauerbrey A; Häfer R; Zintl F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):219-26. PubMed ID: 2475400
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow Th2 cytokine expression as predictor for relapse in childhood acute lymphoblastic leukemia (ALL).
Stachel D; Albert M; Meilbeck R; Kreutzer B; Haas RJ; Schmid I
Eur J Med Res; 2006 Mar; 11(3):102-13. PubMed ID: 16751110
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
Liu YR; Chang Y; Fu JY; Cheng YF; Zhang LP; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):335-8. PubMed ID: 16875586
[TBL] [Abstract][Full Text] [Related]
37. Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: a Pediatric Oncology Group study.
Koehler M; Behm FG; Shuster J; Crist W; Borowitz M; Look AT; Head D; Carroll AJ; Land V; Steuber P
Leukemia; 1993 Dec; 7(12):2064-8. PubMed ID: 8255107
[TBL] [Abstract][Full Text] [Related]
38. Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome.
Karrman K; Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Ehrencrona H; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Palmqvist L; Johansson B; ; ;
Genes Chromosomes Cancer; 2009 Sep; 48(9):795-805. PubMed ID: 19530250
[TBL] [Abstract][Full Text] [Related]
39. Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia.
Shen HQ; Feng JH; Tang YM; Song H; Yang SL; Shi SW; Xu WQ
Leuk Res; 2013 Jun; 37(6):671-4. PubMed ID: 23453285
[TBL] [Abstract][Full Text] [Related]
40. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
